1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Laederach, A. Andreotti, A.H. Fulton, D.B. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 41 12359 12368 10.1021/bi026185z 12369825 Solution and micelle-bound structures of tachyplesin I and its active linear derivatives 2002 10.2210/pdb1ma6/pdb pdb_00001ma6 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2514.931 Tachyplesin I C3Y, C7Y, C12Y, C16Y 1 syn polymer no no KWYFRVYYRGIYYRRYR KWYFRVYYRGIYYRRYR A polypeptide(L) n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-10-16 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details Tachyplesin I solution structure in water TPY4 solution structure in water Tachyplesin I in the presence of 300 mM dodecylphosphocholine micelles RCSB Y RCSB 2002-07-31 REL REL The peptide was chemically synthesized using Fmoc solid state synthesis. The sequence of the peptide is naturally found in Tachypleus Tridentatus (Japanese Horeshoe Crab). sample This structure was determined using standard 2D homonuclear techniques. A temperature of 313K was used to reduce spectral overlap. structures with the lowest energy 300 31 2D NOESY 2D TOCSY 0.15% 3.0 ambient 313 K Simulated annealing with complete cross validation 1 minimized average structure TPY4 mutant of Tachyplesin I 1mM 300 mM Dodecylphosphocholine (D38) 90%/10% H2O/D2O with 0.15% TFA pH 3.0 Brunger, Adams, Clore, DeLano, Gros, Grosse-Kunstleve, Jiang, Kuszewski, Nilges, Pannu, Read, Rice, Simonson, Warren structure solution CNS 1.0 Bruker processing XwinNMR 6.1 Brunger, Adams, Clore, DeLano, Gros, Grosse-Kunstleve, Jiang, Kuszewski, Nilges, Pannu, Read, Rice, Simonson, Warren refinement CNS 1.0 500 Bruker DRX LYS 1 n 1 LYS 1 A TRP 2 n 2 TRP 2 A TYR 3 n 3 TYR 3 A PHE 4 n 4 PHE 4 A ARG 5 n 5 ARG 5 A VAL 6 n 6 VAL 6 A TYR 7 n 7 TYR 7 A TYR 8 n 8 TYR 8 A ARG 9 n 9 ARG 9 A GLY 10 n 10 GLY 10 A ILE 11 n 11 ILE 11 A TYR 12 n 12 TYR 12 A TYR 13 n 13 TYR 13 A ARG 14 n 14 ARG 14 A ARG 15 n 15 ARG 15 A TYR 16 n 16 TYR 16 A ARG 17 n 17 ARG 17 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 5 A A O HE TYR ARG 3 5 1.58 6 A A HG3 H ARG GLY 9 10 1.30 6 A A O N ARG ILE 9 11 2.19 8 A A O H TYR ARG 3 5 1.59 12 A A HE3 H TRP TYR 2 3 1.34 14 A A O H GLY TYR 10 12 1.58 24 A A O H TYR ARG 12 14 1.57 25 A A O N ARG ILE 9 11 2.13 26 A A C HD1 TRP TYR 2 3 1.51 27 A A HH11 HD12 ARG ILE 5 11 1.31 28 A A O H ARG TYR 5 7 1.49 30 A A O H ARG TYR 5 7 1.45 30 A A O HE PHE ARG 4 5 1.56 30 A A HD1 N TYR ARG 8 9 1.58 1 A TRP 2 -57.48 -80.10 1 A TYR 3 -121.39 -142.05 1 A PHE 4 -24.83 -34.90 1 A VAL 6 35.14 70.24 1 A TYR 7 -146.28 14.08 1 A TYR 8 -139.54 -89.29 1 A ARG 9 103.54 116.41 2 A TRP 2 -82.63 -105.66 2 A TYR 3 -142.77 -111.77 2 A PHE 4 -66.52 55.23 2 A ARG 5 175.38 36.92 2 A VAL 6 -69.98 70.58 2 A TYR 8 -135.42 -76.75 2 A ARG 9 96.90 128.44 2 A ARG 14 -115.15 -83.31 2 A ARG 15 24.44 -86.12 2 A TYR 16 57.69 166.93 3 A TRP 2 -53.41 -97.05 3 A TYR 3 -122.55 -127.12 3 A VAL 6 22.87 66.72 3 A TYR 7 -153.32 23.74 3 A TYR 8 -137.62 -94.41 3 A ARG 9 -160.38 -61.91 3 A ILE 11 -25.24 -76.31 3 A TYR 16 60.54 119.28 4 A TRP 2 69.69 -14.20 4 A TYR 3 -141.27 -79.39 4 A PHE 4 -65.07 64.11 4 A ARG 5 170.76 -46.63 4 A VAL 6 36.65 69.39 4 A TYR 7 -152.01 13.45 4 A ARG 9 -176.43 72.46 4 A ILE 11 -35.40 -74.09 4 A TYR 12 168.05 -28.93 4 A TYR 16 -46.93 171.78 5 A TYR 3 125.08 -150.70 5 A PHE 4 -12.91 78.97 5 A ARG 5 155.60 -51.11 5 A VAL 6 34.73 66.72 5 A TYR 7 -149.74 11.84 5 A ARG 9 -151.66 -25.36 5 A ARG 15 -45.16 -75.03 5 A TYR 16 68.11 -66.64 6 A TRP 2 -68.43 -103.26 6 A TYR 3 -146.79 -37.89 6 A VAL 6 39.91 29.52 6 A TYR 8 -161.74 -78.93 6 A ARG 9 115.22 -153.33 6 A TYR 16 -45.52 150.15 7 A TRP 2 -77.70 -102.41 7 A TYR 3 -98.42 -122.48 7 A PHE 4 -62.53 -70.51 7 A ARG 5 -68.35 -70.11 7 A VAL 6 63.39 -60.95 7 A TYR 7 37.44 25.03 7 A ARG 14 -135.60 -63.56 7 A TYR 16 57.01 166.81 8 A TRP 2 -48.49 -86.46 8 A TYR 3 164.21 -65.26 8 A PHE 4 -58.19 53.31 8 A ARG 5 165.92 -35.38 8 A VAL 6 25.62 72.77 8 A TYR 7 -171.96 21.19 8 A ARG 9 -156.00 69.99 8 A TYR 12 47.44 26.60 8 A ARG 14 -174.20 -32.24 9 A TRP 2 38.91 -149.38 9 A TYR 3 -134.71 -123.99 9 A PHE 4 -32.90 -31.18 9 A VAL 6 35.71 68.02 9 A TYR 13 -74.58 -70.72 10 A TRP 2 33.22 95.94 10 A TYR 3 88.13 -161.54 10 A PHE 4 -14.50 -62.93 10 A VAL 6 37.60 73.11 10 A TYR 7 -167.64 28.46 10 A TYR 8 -145.47 -127.21 10 A ARG 9 174.42 35.26 10 A ILE 11 69.87 -49.57 10 A TYR 12 76.16 34.52 11 A TRP 2 -37.88 95.68 11 A TYR 3 -34.62 -121.20 11 A PHE 4 -25.63 75.69 11 A ARG 5 149.04 -54.60 11 A VAL 6 36.96 69.22 11 A TYR 8 -113.56 -81.32 11 A ARG 9 178.30 -38.98 11 A ILE 11 -38.62 -81.27 11 A TYR 12 177.74 35.81 11 A TYR 16 -50.72 171.67 12 A TRP 2 -24.94 -37.58 12 A TYR 3 -172.79 -90.32 12 A VAL 6 39.50 68.11 12 A TYR 7 -156.15 22.20 12 A TYR 12 63.33 67.54 13 A TRP 2 -50.88 -81.34 13 A TYR 3 -127.18 -124.33 13 A ARG 5 84.33 -48.83 13 A VAL 6 32.02 67.47 13 A TYR 7 -143.20 16.99 13 A TYR 8 -142.43 -118.29 13 A ARG 9 151.04 -67.78 13 A TYR 13 34.70 -88.65 13 A ARG 14 -101.56 -78.31 13 A ARG 15 32.36 -89.61 13 A TYR 16 38.06 34.25 14 A TRP 2 -62.81 -84.39 14 A TYR 3 -129.41 -123.29 14 A PHE 4 -7.42 -72.13 14 A VAL 6 35.73 68.14 14 A TYR 7 -143.66 -43.60 14 A ILE 11 63.97 -45.12 14 A TYR 12 72.79 45.30 15 A TYR 3 -154.51 -113.79 15 A PHE 4 -45.69 -7.63 15 A ARG 5 -156.95 34.65 15 A TYR 7 -147.89 16.57 15 A TYR 8 -142.15 -93.48 15 A ARG 9 159.15 36.60 15 A ILE 11 70.86 -63.94 15 A TYR 16 57.22 -158.04 16 A TRP 2 -102.69 -102.44 16 A TYR 3 -91.57 -98.02 16 A PHE 4 -55.35 -71.24 16 A ARG 5 -75.63 -76.38 16 A TYR 8 -124.03 -152.73 16 A ILE 11 -22.51 145.89 16 A TYR 13 52.78 -70.61 16 A ARG 14 -105.13 -80.38 16 A ARG 15 25.51 -124.96 16 A TYR 16 71.25 -70.71 17 A TRP 2 -54.22 -81.28 17 A PHE 4 23.77 -65.60 17 A VAL 6 35.92 69.11 17 A TYR 8 -107.72 -84.35 17 A ARG 9 154.84 81.25 17 A TYR 16 63.19 -78.62 18 A TRP 2 94.33 -88.91 18 A TYR 3 -151.29 -76.56 18 A VAL 6 42.25 28.65 18 A TYR 8 -144.89 -80.94 18 A ARG 9 -174.13 -65.58 18 A TYR 12 31.16 35.78 18 A ARG 15 -69.67 79.66 19 A TRP 2 -81.07 -114.14 19 A TYR 3 -163.94 -76.77 19 A ARG 5 -131.79 -39.16 19 A TYR 8 -135.85 -108.10 19 A ARG 9 150.04 -71.33 19 A ILE 11 -35.88 158.33 19 A TYR 12 -85.35 43.18 19 A TYR 16 -27.36 -46.31 20 A TRP 2 -23.65 -41.47 20 A TYR 3 -102.83 -130.24 20 A PHE 4 -20.78 -43.48 20 A VAL 6 40.71 29.58 20 A TYR 8 -133.73 -70.27 20 A ARG 9 92.35 124.29 20 A ILE 11 -0.34 -59.88 20 A TYR 12 110.76 -0.58 21 A TRP 2 -66.62 -105.27 21 A TYR 3 -164.72 -145.32 21 A PHE 4 -0.13 61.71 21 A ARG 5 157.67 -50.98 21 A ARG 9 -33.80 -35.26 21 A ILE 11 179.01 -37.67 21 A TYR 12 77.94 33.06 21 A ARG 15 -102.57 -71.59 21 A TYR 16 51.01 99.09 22 A TYR 3 125.02 -161.55 22 A PHE 4 7.76 -74.99 22 A VAL 6 45.07 18.99 22 A ARG 9 -65.54 -150.36 22 A ILE 11 21.53 -81.75 22 A TYR 12 170.38 -1.69 22 A ARG 15 -81.50 -85.18 23 A TYR 3 -138.98 -88.28 23 A PHE 4 -50.29 19.42 23 A ARG 5 -168.93 -37.79 23 A VAL 6 37.01 84.47 23 A TYR 7 -145.43 -0.55 23 A TYR 8 -137.94 -78.29 23 A ARG 9 111.92 -33.75 23 A TYR 12 -93.57 50.52 23 A TYR 13 -53.29 -117.62 24 A TYR 3 -176.37 -157.54 24 A PHE 4 -38.87 148.57 24 A ARG 5 96.89 -45.27 24 A VAL 6 24.87 88.21 24 A TYR 7 -152.25 13.12 24 A TYR 8 -128.68 -107.06 24 A ARG 9 -157.68 -42.87 24 A TYR 12 72.47 -58.98 24 A TYR 13 52.44 -62.11 24 A ARG 14 -153.86 37.70 24 A TYR 16 -45.28 -70.31 25 A TYR 3 -131.54 -102.20 25 A VAL 6 39.48 71.39 25 A TYR 7 -157.16 14.78 25 A TYR 8 -171.57 -35.60 25 A ARG 9 52.45 -100.04 25 A ILE 11 -97.93 -64.43 25 A TYR 12 169.27 -20.56 26 A TRP 2 -96.48 -119.22 26 A TYR 3 -153.50 -76.30 26 A VAL 6 7.82 52.24 26 A ILE 11 45.05 -102.37 26 A TYR 12 172.76 31.01 26 A TYR 16 -105.55 77.87 27 A TRP 2 -89.79 -108.22 27 A TYR 3 -99.50 -97.99 27 A PHE 4 -63.80 55.36 27 A ARG 5 -162.42 -70.33 27 A VAL 6 43.76 4.47 27 A ARG 14 -131.96 -77.63 27 A ARG 15 44.76 -83.57 28 A TRP 2 -57.95 -95.71 28 A TYR 3 -115.34 -120.91 28 A PHE 4 -60.44 -70.93 28 A VAL 6 59.07 -51.59 28 A TYR 7 47.02 8.16 28 A ILE 11 -24.31 -65.34 29 A TRP 2 -12.09 79.29 29 A TYR 3 13.93 -91.89 29 A PHE 4 -57.84 57.89 29 A ARG 5 171.05 -46.66 29 A VAL 6 30.68 56.21 29 A TYR 7 -151.75 23.41 29 A TYR 12 85.28 30.83 29 A ARG 15 -50.97 109.52 30 A TYR 3 28.76 -167.76 30 A PHE 4 11.38 36.95 30 A ARG 5 -152.32 -63.09 30 A VAL 6 56.21 -42.14 30 A ARG 9 71.45 -52.78 30 A ILE 11 -5.18 -86.00 30 A TYR 12 134.33 -11.06 31 A TYR 3 -173.86 -86.72 31 A PHE 4 -64.16 62.25 31 A ARG 5 168.87 -55.67 31 A VAL 6 37.11 71.36 31 A ILE 11 -46.53 172.18 31 A TYR 13 -93.96 -91.21 minimized average TPY4 Tachyplesin I tyrosine mutant in the presence of dodecylphosphocholine micelles (300 mM) 1 N N ANTIMICROBIAL PROTEIN Tachyplesin I, TPY4, dodecylphosphocholine, micelle, beta hairpin, ANTIMICROBIAL PROTEIN TAC1_TACTR UNP 1 24 P14213 KWCFRVCYRGICYRRCR 24 40 1MA6 1 17 P14213 A 1 1 17 1 CYS engineered mutation TYR 3 1MA6 A P14213 UNP 26 3 1 CYS engineered mutation TYR 7 1MA6 A P14213 UNP 30 7 1 CYS engineered mutation TYR 12 1MA6 A P14213 UNP 35 12 1 CYS engineered mutation TYR 16 1MA6 A P14213 UNP 39 16